India Pharma Poised to Lead Global Biologics Boom as Government Unveils Mega Initiatives
New Delhi, Apr 13 India is strategically positioned to assume a leading role in the rapidly evolving global pharmaceutical landscape. With the industry shifting focus towards biologics, biosimilars, and...
biologics
biopharma shakti
biosimilars
drug discovery
generic drugs
government policy
high-tech medicine
indian pharmaceuticals
pharmaceutical industry
regulatory reform
India Targets 5 to 6 Percent Global Chemical Share by 2030, Eyes $1 Trillion Turnover by 2040
Government Bets on Bio-Pharma SHAKTI and Chemical Parks to Boost Sector Growth
New Delhi, March 4: India is positioning itself for a major leap in the global chemical and biopharmaceutical landscape...
bio-pharma
biologics
biosimilars
cdsco
chemical parks
chemical sector
circular economy
drug development
fermentation
india
infrastructure
niper
patent expiration
research and development
turnover
State Contributes 21% to India’s BioEconomy, Over 10% to GSDP
Bengaluru, February 23: Karnataka’s BioEconomy is projected to reach USD 39.2 billion in 2025, marking a significant rise from previous years and reaffirming the state’s leadership in the biotechnology sector at the national level...
